GHRP-2 + CJC-1295 Blend (10 mg Vial) Dosage Protocol
GHRP-2 + CJC-1295 (no-DAC) blend pairs the strong GH pulse of GHRP-2 with the sustained GHRH stimulation of CJC-1295 for amplified pulsatile GH release.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 150 mcg (0.15 mg) | 4.5 units (0.045 mL) |
| Weeks 3–12 | 300 mcg (0.30 mg) | 9 units (0.09 mL) |
Frequency: Tie timing to the research design. Human work supports acute synergistic GH release when GHRH and a growth hormone-releasing peptide are combined. The cited study used controlled intravenous administration and does not define a bedtime subcutaneous schedule for this exact blend.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall; avoid foaming.
- Gently swirl/roll until dissolved (do not shake).
- Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Advanced / Twice-Daily Approach (3 mL = ~3.33 mg/mL)
Some protocols split the daily dose into two administrations (morning upon waking, fasted; and evening before bed) to enhance GH pulsatility. Ensure doses are at least 3–8 hours apart to avoid overlapping GH pulses.
| Week | Dose per Injection (mcg) | Units (per injection) (mL) | Total Daily (mcg) |
|---|---|---|---|
| Weeks 1–2 | 100 mcg (0.10 mg) | 3 units (0.03 mL) | 200 mcg |
| Weeks 3–12 | 150 mcg (0.15 mg) | 4.5 units (0.045 mL) | 300 mcg |
For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on an 8–16 week daily protocol with gradual titration (once-daily schedule).
| Item | Quantity |
|---|---|
| Peptide Vials (CJC-1295 + GHRP-2, 10 mg each) | 8 weeks ≈ 2 vials 12 weeks ≈ 3 vials 16 weeks ≈ 4 vials |
| Insulin Syringes (U-100) | Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes |
| Bacteriostatic Water (10 mL bottles) | 8 weeks (2 vials): 6 mL → 1 × 10 mL bottle 12 weeks (3 vials): 9 mL → 1 × 10 mL bottle 16 weeks (4 vials): 12 mL → 2 × 10 mL bottles |
| Alcohol Swabs | Per week: 14 swabs (2/day) 8 weeks: 112 swabs → recommend 2 × 100-count boxes 12 weeks: 168 swabs → recommend 2 × 100-count boxes 16 weeks: 224 swabs → recommend 3 × 100-count boxes |
Protocol Overview
Same GHRH+GHRP synergy with stronger GH pulse, but with significant appetite increase via ghrelin pathway activation.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 28 days, protect from light |
Important Notes
How This Works
Same GHRP + GHRH synergy as the CJC-1295/Ipamorelin blend, but using GHRP-2 instead. Result is a stronger GH pulse with some cortisol and appetite stimulation. Used when appetite increase is desirable.
Potential Benefits & Side Effects
Potential Benefits
- Larger GH pulse than either component alone.
- Appetite stimulation via GHRP-2.
Side Effect Profile
- Cortisol/prolactin elevation.
- Appetite increase.
- Injection-site reactions.
Lifestyle Factors
- Avoid eating for 30+ min post-dose.
- Plan meals to manage appetite.
Injection Technique
- Subcutaneous, rotate sites with each dose.